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1. Introduction 
While an increasing absolute number of elderly people – or any other age group – will 
inevitably increase total healthcare expenditures per year, the expenditure per capita per year 
will not necessarily increase, although this is a common belief. It has been assumed that as 
individual healthcare expenditure in general increases by age, healthcare expenditure per capita 
can be predicted to increase with an ageing population. This common-sense type of reasoning 
has nevertheless not been unanimously supported by previous studies, for at least three reasons:  
First, healthcare expenditures are not only determined by demographic factors, but also by non-
demographic variables, such as technology and economic and institutional characteristics, which 
are amenable by political and managerial decisions. A partial view on the demand pressure may 
therefore bias and exaggerate the effects of ageing on actual spending. 
Second, increasing healthcare costs by increasing age may be partially explained by the lack of 
accounting for the high costs of dying. It has been found that healthcare costs increase rapidly 
with increasing proximity to death. Consequently, if death is postponed, the high costs will 
occur at a later age. This does not necessarily imply higher costs per year per capita.  
Third, even if ageing means higher costs for the older population group, total budgets might 
simply be re-allocated within a certain overall budget ceiling for healthcare expenditure – at 
least in countries where there is a strong political influence on healthcare budgets, as is the case 
in most EU countries. 
1.1  Longevity and health scenarios 
Various scenarios for longevity and health status and the derived costs of health and long-term 
care have been formulated. In an optimistic scenario, morbidity is compressed, that is, while life 
expectancy is assumed to have reached a maximum, the time spent in good health increases. As 
a consequence, the time spent in bad health and in need of healthcare at the end of life becomes 
shorter. This has been termed the ‘compression of morbidity’ scenario. 
In contrast, in a pessimistic scenario life expectancy is assumed to increase. It is furthermore 
assumed that the age-specific risks of health problems are constant. This implies that the time 
spent in bad health increases by increasing life expectancy – the “expansion of morbidity” 
scenario.   
Combinations of these two scenarios are possible, of course. Thus, a ‘dynamic equilibrium 
hypothesis’ implies that longevity increases result in more years in ‘good’ life (the ‘healthy 
ageing’ scenario). As a consequence of this scenario, the number of years spent in bad health is 
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1.2  Review of the empirical literature 
No firm conclusion can be drawn from the existing literature. When analysing the determinants 
of healthcare spending, a distinction should be made between analyses based on individuals as 
the unit of observation (micro-level studies) which are usually restricted to a single country, and 
analyses based on aggregated healthcare spending with countries as the unit of observation 
(macro-level studies). Micro-level studies are often used to make predictions of healthcare 
spending, based on assumptions on age-specific utilisation rates, while macro level studies are 
used to find economic, demographic and institutional determinants of expenditure on historical 
data. While micro-level studies are based on the demand side alone, macro-level studies allow 
for both supply and demand factors to be included. 
2. The  study 
2.1 Purpose 
The main purpose of this paper is to investigate the relationship between ageing and aggregate 
healthcare expenditure in EU countries on a macroeconomic level when including economic and 
institutional variables.  
2.2 Data 
Data were collected form 26 countries covering up to a 24 year period. The countries included 
were the old 15 EU member states (EU15) and the 10 new member states (of which Cyprus and 
Malta were omitted from the final analysis) plus two anticipated members (Romania and 
Bulgaria) and one potential member (Turkey). This group is named EU11 for short in the 
present paper. Variables include economic, social, demographic and institutional factors, as well 
as variables related to capacity and production technology in the healthcare sector. For the 
EU11 countries in particular, data were incomplete. 
2.3 Model 
We hypothesise that ageing affects healthcare expenditures directly as well as indirectly through 
a political process where broad institutional variables are amended due to demand pressure from 
an ageing population, see Figure 1. A number of models were estimated in order to examine the 
impact of ageing, as well as the mediating effects of other variables. Due to imperfect data, 
EU11 countries were analysed for 1990 – 2004 while EU15 countries were analysed for the 
period 1980-2004. Model results were used for extrapolation of the total healthcare expenditure 
over the next 10 years, as an illustration of forecast. 
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Figure 1. 
 
2.4 Variables 
The analyses seek to explain total healthcare expenditure per capita as measured in US dollars, 
adjusted for purchasing power parities (PPP) and inflation. The variables that were used to 
explain healthcare expenditure include the following groups:  
The first group of variables are considered ‘demand variables’ and include the economic 
variable GDP per capita, two behavioural variables (tobacco and alcohol consumption) and two 
social variables (female labour force participation and unemployment rate). The age structure 
variables and life expectancy are included as demographic variables. Age composition is of 
particular interest for the purposes of the present study and will therefore be analysed in detail. 
Thus, we distinguish between two age groups of older people.  
The second group of variables may be loosely termed as ‘supply variables’ which includes 
characteristics of each country’s healthcare system in the period 1980-2003. This list includes 
variables that describe institutional factors assumed to affect utilisation, and variables that are 
used as indicators of capacity and production technology in healthcare.  
In addition to this list of variables, we included a variable indicating each specific country. This 
variable accounts for the specific characteristics of each country. 
3. Results 
It appears that there is a rather high correlation between income per capita and healthcare 
expenditure per capita for the EU15 countries as well as the EU11 countries. In both groups of 
countries, there is a tendency towards richer countries having higher percentages aged people in 
the population. More remarkable is that richer countries in both groups of countries tend to have 
a higher share of the ‘oldest old’ in their populations. For the age group 65-74 years the 
association between healthcare expenditure and income per capita seems to be much closer for 
the EU11 countries than for the EU15 countries.  
       Ageing 
Healthcare 
expenditure 
Institutional 
characteristics, 
technology and 
capacity  
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In the simplest model, only age composition was used to explain variation in total healthcare 
expenditure. Here, it was found that ageing appeared to be associated with healthcare 
expenditure per capita in both groups of countries. The association was negative for the 
youngest among the old age group (increase in age implies lower expenditures) and positive for 
the oldest group. The effect of a one percent unit increase in one of each age group is shown in 
Table 1. Thus, an increase of a one per cent unit of the age group 75+ years in EU15 countries 
implies an increase of about 1/5 percent in healthcare expenditures. 
Table 1. Effect of ageing on healthcare expenditure per capita: Regression analysis with age 
composition as the only explanatory variables 
 EU15  EU11 
Age 65-74 years  -0.06***  -0.31*** 
Age 75+ years  0.19***  0.16** 
Note. The table is based on a model, where characteristics of each country have not been taken into account. 
*** Statistical significant at a 1% level; ** at a 5 % level. The coefficients show the effect of a one % unit 
increase in an age group on total healthcare expenditure per capita, measured as a % change. 
However, in more elaborate models mirroring Figure 1. These effects tended to disappear when 
controlling for health system characteristics and other variables in EU15 countries, while there 
is a positive association in EU11 countries, as seen from Table 2. In both groups of countries it 
seems to be the case that what governs healthcare expenditure is income, specific population 
characteristics, and the presence of specific institutional structures and healthcare technology 
benefiting very old people, rather than the proportion of the population being old. While this 
supports the hypothesis of an indirect effect of ageing through institutional and healthcare 
technology variables, this should be interpreted cautiously. 
Table 2. Effect of ageing on healthcare expenditure per capita: Analysis with inclusion of 
demand and supply variables and a variable indicating characteristics of each specific 
country 
 EU15  EU11 
Age 65-74 years  0.01  0.22*** 
Age 75+ years  -0.11  0.07 
*** Statistical significant at a 1% level. The coefficients show the effect of a one % unit increase in an age 
group on total healthcare expenditure per capita, measured as a % change. 
  
Discussion 
The study is based upon historical data which may give an insight into the mechanisms at play 
but do not predict future changes. It is concluded that the direct effect of demand for healthcare 
due to ageing is very small, and in EU15 countries the effect is insignificant. An apparent 
association between ageing and expenditure in EU15 countries may be explained by income: 
richer countries have a larger share of the aged population and can afford to invest in expensive 
technology.  
This may indicate that GDP is not that important for the share of the population being in the age 
group 65-74 years in the richer EU15 because they have increased life expectancy with their DETERMINANTS OF AGGREGATE HEALTHCARE EXPENDITURE FOCUSING ON AGE COMPOSITION | 5 
 
wealth levels whereas GDP is still an important determinant of the share of the population in the 
age group 65-74 year in the less wealthy EU11 countries. 
Technology changes may affect the costs of care for all age groups, but potentially differently. It 
is an empirical question as to whether improved technology will affect the older age groups 
more than the rest. It appeared that there was only a statistically significant positive association 
between expenditure and indicators of technology in EU15 countries. 
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